MUC1 Glycopeptide Vaccine Modified with a GalNAc Glycocluster Targets the Macrophage Galactose C-type Lectin on Dendritic Cells to Elicit an Improved Humoral Response
Journal of the American Chemical Society · 21.06.2023 · 145 (24) · 13027-13037
DOI: 10.1021/jacs.2c12843 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 06.06.2023. Verfasst von Adele Gabba und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological and Chemical Sciences, University of Galway, University Rd., H91 TK33 Galway, Ireland. Hauptthemen laut MEDLINE: Mucin-1, Vaccines. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Foundation Ireland, Kempestiftelserna, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biological and Chemical Sciences, University of Galway, University Rd., H91 TK33 Galway, Ireland.
- Department of Chemistry, Johannes Gutenberg University Mainz, Duesbergweg 10-14, 55128 Mainz, Germany.
- Institute of Immunology, University Medical Center Mainz, Langenbeckstr.1, 55131 Mainz, Germany.
- Department of Chemistry, Umeå University, KBC-Building, Linneaus väg 6, S-907 36 Umeå, Sweden.
- Department of Molecular Cell Biology and Immunology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands.
- Amsterdam Institute for Infection and Immunity, Cancer Immunology1105 AZ Amsterdam, the Netherlands.
ORCID-Profile: Adele Gabba, Gabriel Birrane, Pol Besenius, Paul V Murphy
Förderung
- Science Foundation Ireland
- Kempestiftelserna
- Deutsche Forschungsgemeinschaft
- H2020 European Research Council
- Irish Research Council for Science, Engineering and Technology
- European Molecular Biology Organization
Zitieren
APA
Gabba, A., Attariya, R., Behren, S., Pett, C., van der Horst, J. C., Yurugi, H., Yu, J., Urschbach, M., Sabin, J., Birrane, G., Schmitt, E., van Vliet, S. J., Besenius, P., Westerlind, U., & Murphy, P. V. (2023). MUC1 Glycopeptide Vaccine Modified with a GalNAc Glycocluster Targets the Macrophage Galactose C-type Lectin on Dendritic Cells to Elicit an Improved Humoral Response. Journal of the American Chemical Society, 145(24), 13027-13037. https://doi.org/10.1021/jacs.2c12843
Vancouver
Gabba A, Attariya R, Behren S, Pett C, van der Horst JC, Yurugi H, et al. MUC1 Glycopeptide Vaccine Modified with a GalNAc Glycocluster Targets the Macrophage Galactose C-type Lectin on Dendritic Cells to Elicit an Improved Humoral Response. Journal of the American Chemical Society. 2023;145(24):13027-13037. doi:10.1021/jacs.2c12843
BibTeX
@article{Gabba2023,
author = {Gabba, Adele and Attariya, Riem and Behren, Sandra and Pett, Christian and van der Horst, Joost C and Yurugi, Hajime and Yu, Jin and Urschbach, Moritz and Sabin, Juan and Birrane, Gabriel and Schmitt, Edgar and van Vliet, Sandra J and Besenius, Pol and Westerlind, Ulrika and Murphy, Paul V},
title = {MUC1 Glycopeptide Vaccine Modified with a GalNAc Glycocluster Targets the Macrophage Galactose C-type Lectin on Dendritic Cells to Elicit an Improved Humoral Response},
journal = {Journal of the American Chemical Society},
year = {2023},
volume = {145},
number = {24},
pages = {13027--13037},
doi = {10.1021/jacs.2c12843}
}
EUVIMED